TipRanks
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
HALO
Halozyme
RESEARCH TOOLSreports
Want to see HALO full AI Analyst Report?

Halozyme (HALO) Ownership - Who Owns Halozyme?

1,242 Followers

Halozyme (HALO) Ownership Overview

0.92%30.27%28.80%29.86%10.14%
0.92% Insiders
30.27% Mutual Funds
28.80% Other Institutional Investors
29.86% ETFs
10.14% Public Companies and Individual Investors
The ownership structure of Halozyme (HALO) stock is a mix of institutional, retail, and individual investors. Approximately 88.93% of the company’s stock is owned by Institutional Investors, 0.92% is owned by Insiders, and 10.14% is owned by Public Companies and Individual Investors.
The ownership structure of Halozyme (HALO) stock is a mix of institutional, retail, and individual investors. Approximately 59.07% of the company’s stock is owned by Institutional Investors, 0.92% is owned by Insiders, and 29.86% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 10, 2026
Cortney Caudill
xxxxxxxxxxxxx
$1955137
Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
Hussman Strategic Advisors Inc
xxxxxxxxxxxxx
$3287340
Jun 30, 2026
Bridgewater Associates, Lp
xxxxxxxxxxxxx
$36250437
Jun 30, 2026
Gallacher Capital Management Llc
xxxxxxxxxxxxx
$412013
Jun 30, 2026
Fisher Asset Management Llc
xxxxxxxxxxxxx
$33477097
Show More Hedge Fund Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
12,921,902Institution11.39%1,441,567,387
10,398,325Institution9.16%1,160,037,137
9,294,972Institution8.19%1,036,947,076
3,500,794Institution3.08%390,548,579
3,205,964Institution2.82%357,657,344
1,811,277Institution1.60%202,066,062
1,427,415Institution1.26%159,242,417
1,182,985Institution1.04%131,973,807
1,175,300Institution1.04%131,116,468
1,161,811Institution1.02%129,611,635

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
9,294,972Institution8.19%1,036,947,076
3,205,964Institution2.82%357,657,344
1,427,415Institution1.26%159,242,417
1,182,985Institution1.04%131,973,807
1,175,300Institution1.04%131,116,468
1,132,202Institution1.00%126,308,455
1,109,105Institution0.98%123,731,754
1,015,499Institution0.89%113,289,068
882,573Institution0.78%98,459,844
770,023Institution0.68%85,903,766

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
iShares
4,200,163Institution3.70%138,017,356
iShares
4,041,099Institution3.56%450,825,004
Vanguard
3,770,317Institution3.32%401,501,057
Vanguard
2,729,170Institution2.40%290,629,313
Vanguard
1,566,360Institution1.38%166,801,676
SPDR
1,395,498Institution1.23%157,537,769
Vanguard
1,377,941Institution1.21%146,736,937
First Trust
1,188,143Institution1.05%132,549,233
SPDR
841,950Institution0.74%93,927,942
iShares
841,207Institution0.74%93,845,053

FAQ

Who Owns Halozyme Therapeutics (HALO)?
According to the latest TipRanks data, approximately 28.80% of the company's stock is held by institutional investors, 0.92% is held by insiders, and 10.14% is held by retail investors.
    What percentage of Halozyme Therapeutics (HALO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 28.80% of Halozyme Therapeutics (HALO) stock is held by institutional investors.
      What percentage of Halozyme Therapeutics (HALO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 10.14% of Halozyme Therapeutics (HALO) stock is held by retail investors.
        Who owns the most shares of Halozyme Therapeutics (HALO)?
        iShares owns the most shares of Halozyme Therapeutics (HALO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.